279 related articles for article (PubMed ID: 33580904)
1. Trace element alterations in Alzheimer's disease: A review.
Cilliers K
Clin Anat; 2021 Jul; 34(5):766-773. PubMed ID: 33580904
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
Crouch PJ; Barnham KJ; Bush AI; White AR
Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
[TBL] [Abstract][Full Text] [Related]
3. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
4. Imbalances in Copper or Zinc Concentrations Trigger Further Trace Metal Dyshomeostasis in Amyloid-Beta Producing
Metaxas A
Front Neurosci; 2021; 15():755475. PubMed ID: 34707479
[TBL] [Abstract][Full Text] [Related]
5. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
6. Metal complexing agents as therapies for Alzheimer's disease.
Bush AI
Neurobiol Aging; 2002; 23(6):1031-8. PubMed ID: 12470799
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease, metal ions and metal homeostatic therapy.
Zatta P; Drago D; Bolognin S; Sensi SL
Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
[TBL] [Abstract][Full Text] [Related]
8. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
9. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
Domingo JL
J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
[TBL] [Abstract][Full Text] [Related]
10. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
Price KA; Crouch PJ; White AR
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
[TBL] [Abstract][Full Text] [Related]
12. The role of metals in modulating metalloprotease activity in the AD brain.
Filiz G; Price KA; Caragounis A; Du T; Crouch PJ; White AR
Eur Biophys J; 2008 Mar; 37(3):315-21. PubMed ID: 18270696
[TBL] [Abstract][Full Text] [Related]
13. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
14. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
15. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.
Ritchie CW; Bush AI; Mackinnon A; Macfarlane S; Mastwyk M; MacGregor L; Kiers L; Cherny R; Li QX; Tammer A; Carrington D; Mavros C; Volitakis I; Xilinas M; Ames D; Davis S; Beyreuther K; Tanzi RE; Masters CL
Arch Neurol; 2003 Dec; 60(12):1685-91. PubMed ID: 14676042
[TBL] [Abstract][Full Text] [Related]
16. The metallobiology of Alzheimer's disease.
Bush AI
Trends Neurosci; 2003 Apr; 26(4):207-14. PubMed ID: 12689772
[TBL] [Abstract][Full Text] [Related]
17. Common and Trace Metals in Alzheimer's and Parkinson's Diseases.
Doroszkiewicz J; Farhan JA; Mroczko J; Winkel I; Perkowski M; Mroczko B
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958705
[TBL] [Abstract][Full Text] [Related]
18. Therapeutics for Alzheimer's disease based on the metal hypothesis.
Bush AI; Tanzi RE
Neurotherapeutics; 2008 Jul; 5(3):421-32. PubMed ID: 18625454
[TBL] [Abstract][Full Text] [Related]
19. Modulating metals as a therapeutic strategy for Alzheimer's disease.
Hung LW; Barnham KJ
Future Med Chem; 2012 May; 4(8):955-69. PubMed ID: 22650238
[TBL] [Abstract][Full Text] [Related]
20. Current status of metals as therapeutic targets in Alzheimer's disease.
Finefrock AE; Bush AI; Doraiswamy PM
J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]